Coverage
-
August 11, 2016
A New Jersey federal judge on Thursday dismissed Exeltis USA Dermatology Inc.’s trade secrets infringement and unfair competition suit against Acella Pharmaceuticals LLC, concluding that Exeltis failed to explain which proprietary information was taken regarding its skin disorder treatments Salvax and Hydro 35.
1 other articles on this case.
View all »